Tag: OTC Derivatives

UK Response to Derivatives Reform: Protectionism or Pragmatism?

A TABB Group Commentary.  Download free here. Does the UK have a soft spot for OTC derivatives or do they just have a better grasp of reality than the rest of the globe? On 15th December 2009, the UK Financial Services Authority (FSA) and HM Treasury published a joint response to the “EU Consultation Document: […]

Derivatives Regulatory Update Conference – Jan 13, 2010

Conference focused on “Strategies for the Coming Market Reformation I’m giving the keynote address, which will be an overview of the financial reform legislation passed by the House and what it will mean to the industry. I’m also moderating a panel on the same topic. Full Details Here

Futures – Next Step For OTC Regulation

Kevin McPartland, senior analyst at Tabb Group, doesn’t think position limits will force U.S. business overseas. “There is some level of harmonization between the U.S. and regulators in Europe. They’re trying to not create a situation where there’s a lot of regulatory arbitrage. The regulations, although different, won’t be [so] extreme in one jurisdiction that […]

Bloomberg – Regulatory Budgets No Match for Banks in OTC Push, TABB Says

U.S. regulators will need budget increases “orders-of-magnitude larger” than current levels to police trades in the $592 trillion over-the-counter derivatives market, according to Tabb Group analyst Kevin McPartland. Full Article Here TABB Group Report Here